Physician

Rajesh J Patel, M.D.

According to 2025 Medicare claims, Rajesh Patel, M.D. (NPI: 1013985936) practices internal medicine in the Williamsport, PA market, with the plurality of this provider's patient population coming from Lycoming, PA. This provider's primary affiliated billing organization is LYCOMING INTERNAL MEDICINE, INC. (NPI: 1861460867; TIN: 232828842) and primary practice location at 17745-7814. Patel is affiliated with the Keystone ACO (ACO ID: A1552) and PA Clinical Network ACO Inc (ACO ID: A5030), participating under the MSSP model.

Patel's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 203 traditional Medicare patients, billed 2,674 HCPCS/CPT codes, and received $146,733 in Medicare payments. The top billing code was 99310 (Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes). Part D data shows 9,237 prescription claims across 437 beneficiaries totaling $1,476,681 in drug costs, led by Korlym (Mifepristone). DME data shows 145 claims. Open Payments data shows 135 records totaling $18,038. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $986,654 to $1,476,681. In contrast, DME billing represents a smaller volume and started with an early spike, then settled into a lower baseline, moving from $39,962 to $8,915.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	832	6,210	$213,673
2016	796	4,351	$179,590
2017	773	4,410	$171,743
2018	613	4,162	$193,346
2019	451	3,790	$170,506
2020	467	3,216	$170,781
2021	471	2,474	$156,770
2022	390	2,533	$153,230
2023	176	2,197	$135,373
2024	203	2,674	$146,733

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	421	11,247	$986,654
2016	427	10,897	$1,005,815
2017	431	9,891	$847,722
2018	390	9,289	$894,974
2019	400	10,830	$1,064,601
2020	340	10,342	$932,347
2021	339	10,631	$989,102
2022	397	10,466	$1,223,789
2023	367	8,853	$1,207,713
2024	437	9,237	$1,476,681

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	166	764	$52,214
2016	107	653	$32,266
2017	92	575	$27,160
2018	123	556	$28,260
2019	88	489	$24,261
2020	61	288	$9,533
2021	36	268	$9,176
2022	23	182	$7,547
2023	N/R	125	$5,525
2024	N/R	145	$4,265

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99310	Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes	71	237	$115
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	68	172	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	95	317	$60
G0444	Annual depression screening, 5 to 15 minutes	76	76	$18
G0136	Administration of a standardized, evidence-based social determinants of health risk assessment tool, 5-15 minutes	73	125	$14

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Korlym	Mifepristone	11	330	$223,362
Xarelto	Rivaroxaban	281	9,174	$168,628
Eliquis	Apixaban	254	6,361	$123,147
Jardiance	Empagliflozin	154	5,882	$112,201
Rybelsus	Semaglutide	90	3,356	$101,701

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	18	$1,276
A7030	Full face mask used with positive airway pressure device, each	N	N/R	12	$1,012
E0601	Continuous positive airway pressure (cpap) device	Y	N/R	20	$719
A7038	Filter, disposable, used with positive airway pressure device	N	N/R	26	$316
A7035	Headgear used with positive airway pressure device	N	N/R	12	$249

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	133	$17,463	Phathom Pharmaceuticals, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$575	Novo Nordisk AS
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Rajesh J. Patel, M.D.?

Tedicare shows public-source Medicare data for Rajesh J. Patel, M.D. (NPI 1013985936), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Rajesh J. Patel, M.D. have ACO affiliation data?

Rajesh J. Patel, M.D. is shown with ACO affiliation data for Keystone ACO (MSSP, ACO ID A1552) and PA Clinical Network ACO Inc (MSSP, ACO ID A5030).

What billing organization is linked to Rajesh J. Patel, M.D.?

Rajesh J. Patel, M.D. is linked to LYCOMING INTERNAL MEDICINE, INC. (billing NPI 1861460867) in the available physician profile data.

Does Rajesh J. Patel, M.D. have Open Payments data?

Rajesh J. Patel, M.D. has 135 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.